Filing Details

Accession Number:
0001104659-21-035739
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-12 18:33:50
Reporting Period:
2021-03-11
Accepted Time:
2021-03-12 18:33:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124524 Cryoport Inc. CYRX Pharmaceutical Preparations (2834) 880313393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587502 J Edward Zecchini C/O Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood TN 37027
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-11 4,167 $5.04 39,190 No 4 M Direct
Common Stock Disposition 2021-03-11 4,167 $55.65 35,023 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Disposition 2021-03-11 4,167 $0.00 4,167 $5.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-08-29 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.14 to $55.88, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
  3. 1/12 of the options vested on the 24th day of each month for the twelve months beginning on 9/29/2014.